<DOC>
	<DOCNO>NCT02824809</DOCNO>
	<brief_summary>The Aims study estimate association severity COPD free testosterone level prevalence hypogonadism adult men stable COPD</brief_summary>
	<brief_title>Association Between Testosterone Levels COPD Severity</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Adults Men ≥ 45 year COPD define accord clinical diagnosis spirometry American thoracic society ( ATS ) criteria Stable COPD without recent acute exacerbation ( le 2 week ) Refusal participate informed consent process Those treatment testosterone replacement antiandrogens Comorbidities : Cirrhosis , Alcoholism , cryptorchidism , panhypopituitarism , Pituitary adenoma . Orchiectomy Systemic glucocorticoid ( equivalent dose ≥ 4 mg prednisone last 3 week ) . Relative absolute contraindication spirometry .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Severity Illness Index</keyword>
	<keyword>Testosterone</keyword>
</DOC>